When the world gets closer.

We help you see farther.

Sign up to our expressly international daily newsletter.


Why U.S. Vaccine Diplomacy In Latin America Makes "Good" Sense

Echoing its cultural diplomacy of the early 20th century, the United States is gifting vaccines to Latin America as part of a renewed "good neighbor'' policy.


BUENOS AIRES — Just before and during World War II, the United States' Good Neighbor policy proved a very effective strategy to improve ties with Latin America. Initiated by President Franklin D. Roosevelt, the policy's main goal was non-interference and non-intervention. The U.S. would instead focus on reciprocal exchanges with their southern neighbors, including through art and cultural diplomacy.

Watch Video Show less

Where Are The Doses? How U.S. And Europe Vaccine Pledges Look In Africa

Following bold promises from Western leaders to send millions of jabs to the developing world, there is still an extreme shortage in most African countries.

In recent weeks, European Commission President Ursula von Der Leyen and U.S. President Joe Biden have very publicly doubled down on commitments to help vaccinate the whole world against COVID-19, donating hundreds of millions of additional doses to try to save lives in developing countries and defeat the global pandemic once and for all.

"To beat the pandemic here we need to beat it everywhere," Biden said last week announcing the U.S. was buying 500,000 more vaccine doses to share with other countries. "This is an all hands on deck crisis."

Keep reading... Show less

Nix The Patents: The Case For COVID Vaccines As A Public Good

The pandemic is too big a crisis and too unpredictable to respect the normal trade rules governing pharmaceutical developments.


PARIS — Extraordinary times, as the saying goes, call for extraordinary measures, — and nowhere is that more imperative than with the patent regulations governing the recently developed coronavirus vaccines.

In normal circumstances, it takes 10 years before a drug is authorized for sale, plus another 10 years of marketing by a single producer before the patent falls into the public domain as "generic." But in the current context, as the world grapples with an unprecedented crisis, those rules just don't make any sense.

Patents give companies the right not only to produce the vaccines, but to do so exclusively for 20 years.

Remedies are available, but not enough and not for everyone since only a few companies own the patents that give them the right not only to produce the vaccines, but to do so exclusively for 20 years.

That privilege, however, has been overtaken by the historical moment. That exclusivity does take into account the current catastrophe. The 20-year period of private monopoly applied to vaccines for COVID-19 is so absurd, so unsuited to the global situation, that only our ideological ruts prevent us from questioning it. The fact is that we just can't wait for 20 years.

The industrial monopoly on vaccines is dangerous and unfair. It is dangerous because we are wasting precious time. Apart from the financial price, the production and sales system of a few private industries will never be able to keep pace. At this rate, for too long not enough people will be vaccinated and the COVID-19 virus will continue to circulate, kill and mutate all over the world.

With these mutations, other vaccines may be needed and then other treatments will have to be invented, produced and purchased at a high cost. More importantly, much more aggressive forms of the virus could appear.

Yes, we've already adapted to many things since the start of this pandemic. But how will we react the day when, through a mutation, COVID-19 starts killing young people and children? The more time that passes, the less we vaccinate on the five continents and the more we risk random, unanticipated mutations.

These vaccines are a public good; they cannot belong to anyone.

The monopoly and the shortage of vaccines it creates are unfair because they effectively create hierarchies among human beings. They separate and distinguish the rich from the poor, the young from the old, caregivers from educators, workers from the disenfranchised, powerful nations from others, and so on. At the beginning of 2021, the richest countries own and distribute, sometimes at a high cost, the vast majority of existing vaccines. But in whose name? In the name of what?

Today, vaccines and any future treatments must be considered as universal tools or goods, like fire, water or the wheel that no one would ever think of patenting. These vaccines are a public good; they cannot belong to anyone. No right, no ideological fear can justify this exclusivity. Let us fund research rather than the commercial exploitation of patents. These substances should be considered immediately as generics. Moreover, this must be our goal and we must compensate industries for any necessary investments.

Vaccines and any future treatments must be considered as universal tools or goods — Photo: Str/NurPhoto via ZUMA Press

With the global coronavirus pandemic, today more than ever, treating and saving lives is more than a right. It is a duty. All the nations of the world, all the governments, all the laboratories, private as well as public, must be able to produce and distribute the vaccines and treatments necessary to stop this disaster that overwhelms us. There is nothing revolutionary about this idea.

There has already been at least one precedent, with the treatment of AIDS in the 1990s. Faced with the shortage and the exorbitant prices charged by the pharma giants, the governments of several countries (including Brazil and India) decided to produce and distribute free AZT generics to treat their populations. Neither the pharmaceutical industry nor research collapsed, and millions of lives were saved. Let more willing rulers lead the way and others will follow.

In the current context, as the world grapples with an unprecedented crisis, those rules just don't make any sense.

So let it be said: The medical monopoly granted by the purchase of a patent is an undue and anachronistic appropriation of the needs of the whole of humanity in the face of COVID-19. The right to health is universal. The duty of governments to treat is a non-negotiable emergency. Letting this trade law, with its built-in 20-year monopolies, prevail would be an incomprehensible and dramatic error for which the rulers of each country would be the first responsible, and us, their consenting victims.

The question is simple: Should we still leave to some three or four companies the exclusive right to trade, manufacture and distribute vaccines and anti-COVID-19 treatments all over the world? The answer seems obvious.

Keep reading... Show less